Your browser doesn't support javascript.
loading
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer.
Lücking, Ulrich; Scholz, Arne; Lienau, Philip; Siemeister, Gerhard; Kosemund, Dirk; Bohlmann, Rolf; Briem, Hans; Terebesi, Ildiko; Meyer, Kirstin; Prelle, Katja; Denner, Karsten; Bömer, Ulf; Schäfer, Martina; Eis, Knut; Valencia, Ray; Ince, Stuart; von Nussbaum, Franz; Mumberg, Dominik; Ziegelbauer, Karl; Klebl, Bert; Choidas, Axel; Nussbaumer, Peter; Baumann, Matthias; Schultz-Fademrecht, Carsten; Rühter, Gerd; Eickhoff, Jan; Brands, Michael.
Afiliação
  • Lücking U; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Scholz A; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Lienau P; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Siemeister G; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Kosemund D; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Bohlmann R; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Briem H; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Terebesi I; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Meyer K; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Prelle K; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Denner K; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Bömer U; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Schäfer M; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Eis K; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Valencia R; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Ince S; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • von Nussbaum F; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Mumberg D; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Ziegelbauer K; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
  • Klebl B; Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany.
  • Choidas A; Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany.
  • Nussbaumer P; Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany.
  • Baumann M; Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany.
  • Schultz-Fademrecht C; Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany.
  • Rühter G; Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany.
  • Eickhoff J; Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany.
  • Brands M; Bayer AG, Pharmaceuticals Division, Drug Discovery, Müllerstr. 178, 13353, Berlin, Germany.
ChemMedChem ; 12(21): 1776-1793, 2017 11 08.
Article em En | MEDLINE | ID: mdl-28961375
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article